Download video

Dr. Debu Tripathy Discusses the Updated EMILIA Trial Results for T-DM1

154 views

OncLive

12 years ago

Dr. Debu Tripathy Discusses the Updated EMILIA Trial Results for T-DM1

Dr. Debu Tripathy Discusses the Updated EMILIA Trial Results for T-DM1

Dr. Debu Tripathy Discusses the Updated EMILIA Trial Results for T-DM1
1:38
Dr. Debu Tripathy Discusses the Updated EMILIA Trial Results for T-DM1
by OncLive
Debu Tripathy, MD discusses the PALOMA-2 trial outcomes in ER+\/HER2- advanced breast cancer
0:37
Debu Tripathy, MD discusses the PALOMA-2 trial outcomes in ER+\/HER2- advanced breast cancer
by OBRoncology
Dr. Debu Tripathy Reviews the Phase III CONFIRM Trial
1:25
Dr. Debu Tripathy Reviews the Phase III CONFIRM Trial
by OncLive
Dr. Kimberly Blackwell Discusses the T-DM1 EMILIA Trial Coprimary Endpoints
1:04
Dr. Kimberly Blackwell Discusses the T-DM1 EMILIA Trial Coprimary Endpoints
by OncLive
Debu Tripathy, MD, elaborates on the SOPHIA trial in HER+ metastatic breast cancer
1:56
Debu Tripathy, MD, elaborates on the SOPHIA trial in HER+ metastatic breast cancer
by OBRoncology
Debu Tripathy, MD, discusses recent FDA approvals and HER2+ metastatic breast cancer management
4:17
Debu Tripathy, MD, discusses recent FDA approvals and HER2+ metastatic breast cancer management
by OBRoncology
Dr. Tripathy on Trastuzumab Deruxtecan Versus T-DM1 in HER2-Expressing Breast Cancers
1:09
Dr. Tripathy on Trastuzumab Deruxtecan Versus T-DM1 in HER2-Expressing Breast Cancers
by OncLive
Dr. Debu Tripathy Gives an Overview of Targeted Therapies for Breast Cancer
1:22
Dr. Debu Tripathy Gives an Overview of Targeted Therapies for Breast Cancer
by OncLive
Dr. Tripathy on Standard and Emerging Treatment Advances for HER2+ Breast Cancer
1:08
Dr. Tripathy on Standard and Emerging Treatment Advances for HER2+ Breast Cancer
by OncLive
Disc prolapse: Symptoms, treatments, and surgery
9:33
Disc prolapse: Symptoms, treatments, and surgery
by Top Doctors UK
Anti-HER2 Mechanisms of Approved HER2 Inhibitors
5:05
Anti-HER2 Mechanisms of Approved HER2 Inhibitors
by HMP Education
Life to death and back to life
2:48
Life to death and back to life
by drradha krishnan
T-DM1 Shows Promise in HER-Positive Breast Cancer
3:36
T-DM1 Shows Promise in HER-Positive Breast Cancer
by curetoday
Dr. Perez Discusses T-DM1 and the MARIANNE Trial
1:14
Dr. Perez Discusses T-DM1 and the MARIANNE Trial
by Targeted Oncology
Dr. Sramila Aithal on the EMILIA Trial Studying T-DM1 in Metastatic Breast Cancer
2:42
Dr. Sramila Aithal on the EMILIA Trial Studying T-DM1 in Metastatic Breast Cancer
by Targeted Oncology
Dr. Tripathy Discusses Breast Cancer Gene Profiling
0:45
Dr. Tripathy Discusses Breast Cancer Gene Profiling
by OncLive
Debu Tripathy, MD, elaborates on outcomes from the ImPassion130 trial
1:44
Debu Tripathy, MD, elaborates on outcomes from the ImPassion130 trial
by OBRoncology
Dr. Tripathy on Determining the Best HER2 Targeted Therapy
1:06
Dr. Tripathy on Determining the Best HER2 Targeted Therapy
by OncLive
Dr. Tripathy on Neoadjuvant Treatment Strategies in HER2+ Breast Cancer
3:27
Dr. Tripathy on Neoadjuvant Treatment Strategies in HER2+ Breast Cancer
by OncLive
Dr. Tripathy Discusses Pertuzumab in HER2+ Breast Cancer
1:54
Dr. Tripathy Discusses Pertuzumab in HER2+ Breast Cancer
by OncLive
Dr. Tripathy Discusses Immunotherapy in HER2+ Breast Cancer
0:51
Dr. Tripathy Discusses Immunotherapy in HER2+ Breast Cancer
by OncLive
Dr. Mark Pegram Discusses Earlier Treatment With T-DM1
1:52
Dr. Mark Pegram Discusses Earlier Treatment With T-DM1
by OncLive
Dr. Tripathy on Personalized Therapies in Advanced Breast Cancer
3:35
Dr. Tripathy on Personalized Therapies in Advanced Breast Cancer
by Targeted Oncology